VC-backed Principa Biopharma expands executive team with two new hires
Principia Biopharma said Thursday that it has named Christopher Y. Chai as chief financial officer and Dr. Steven G. Gourlay as chief medical officer. Previously, Chai worked at MAP Pharmaceuticals where he served as senior vice president and CFO while Gourlay was a partner at GBS Venture Partners. Based in South San Francisco, Principia Biopharma is a pre-clinical stage company focused on immunology, autoimmune diseases and oncology. Its backers include New Leaf Venture Partners, OrbiMed Advisors, Morgenthaler Ventures, SROne and Mission Bay Capital.
13 February 2014•3 mins read
